Important Update: We are pleased to announce significant enhancements to our FHIR Terminology Server, offering more seamless and standards-based access to terminology content for healthcare data exchange. Discover the new features and upcoming changes to our Terminology Gateway.
Learn More >
This guideline aims to help primary care providers understand the quality of evidence regarding medical cannabinoid prescribing treatment for various conditions. This will allow for shared, evidence-informed conversations with their patients regarding medical cannabinoids as an option for treatment.
Thanks to our working group member Samim Hasham for sharing this resource.
Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.
Print
Email
Medical Cannabinoids Clinical Practice Guideline
Twitter